ApoGen increases 2016 Series A funding round to $11 million
Company draws $4 million in additional funding from Merck KGaA's venture capital arm and other investors.
ApoGen secures $7M Series A with Accelerator Corporation
With a $7 million Series A financing round, ApoGen has become the latest startup to enter Accelerator Corporation's syndicate funding and operational support program. It's a strong endorsement from a firm which makes very few investments.
presented by
The Healthcare Payments Industry Faces a Perception Challenge
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.